Objective: Bronchopulmonary dysplasia (BPD) is a pulmonary disease associated with poor neurodevelopmental and medical outcomes. Patients with BPD are medically fragile, at high risk for complications and require interdisciplinary care. We tested the hypothesis that a chronic care approach for BPD would improve neurodevelopmental outcomes relative to the National Institute of Child and Human Development Neonatal Research Network (NICHD NRN) and reduce medical complications.
Introduction
Bronchopulmonary dysplasia (BPD) is the most common pulmonary complication of prematurity, and the prevention of and the optimal treatment for BPD is a major concern for neonatal centers. Although recent advances in care and technology have lead to improved survival of very-low birth-weight infants, they have not reduced the rates of BPD in survivors. [1] [2] [3] [4] [5] Unfortunately, rates of prematurity are generally increasing, particularly among minorities and those in low socioeconomic classes, and the absolute numbers of extremely premature infants surviving with BPD is likely increasing.
In addition to directly causing respiratory complications, the presence of BPD is strongly associated with poor neurodevelopmental outcomes, and the severity of neurological impairment is directly related to BPD severity. 6 Such delays often cause permanent disability. Moreover, the medical complications of BPD do not end at discharge, as infants sent home on oxygen therapy are more likely to develop severe lower respiratory tract infections, to have reactive airways disease, to be readmitted to the hospital, and to die within the first year of life. [1] [2] [3] 7, 8 Finally, such patients are disproportionately born to socioeconomically disadvantaged families, making complex, preventative medical care challenging.
In 2003, the American Thoracic Society compiled a statement indicating the critical topics required for the care of a child with BPD. 9 They identified several areas of emphasis, including nutritional and neurodevelopmental issues, home care concerns and well-child care. The diversity of these clinical needs suggests that an interdisciplinary team approach is necessary to provide optimal care for infants and families facing BPD.
To address these needs and to provide a consistent care-giving model, we have developed the Comprehensive Center for Bronchopulmonary Dysplasia (CCBPD) at Nationwide Children's Hospital. We designed this program using several principles from a chronic care model, 10 including (a) the use of interdisciplinary care teams that included occupational therapists and physical therapists (OT and PT) addressing neurobehavioral skills, (b) protocol-based guidance of interventions and (c) comprehensive care extending to outpatient care after discharge. This paper describes the CCBPD and reports neurodevelopmental outcomes and readmission rates as initial measures of success.
Program description
The CCBPD strives to foster relationships between the healthcare team and families of infants with BPD. This collaboration is intended to address the infants' and families' needs, to improve long-term outcomes and to minimize emergency room visits and hospital re-admissions. Involvement with the CCBPD begins while the infants are still hospitalized (often as early as 28 days of life), continues during the transition to home, and typically ceases at 2-3 years of life. A thorough developmental assessment is carried out on every infant before discharge from the BPD outpatient clinic.
The interdisciplinary BPD team consists of a core group of neonatologists, pulmonologists, nurse practitioners, nurses, nutritionists, OTs and PTs, social workers, case managers, pharmacists, speech therapists, respiratory therapists, parent support people and pediatricians. The composition of the team is designed to address the individualized, and often highly complex, needs of the infant and family. The mission of the BPD team is two-fold. First, we serve each infant and family by using the latest evidence-based practice and research to continuously improve care. Second, we foster a physical and therapeutic environment that empowers the family to actively participate in the care of their child.
Inpatient program
Once diagnosed with BPD, the infant is transitioned from our acute care neonatal intensive care unit to our chronic care neonatal intensive care unit, which is designed to facilitate the physical and sensory development of an infant with BPD. This neonatal intensive care unit provides private rooms to encourage family participation, large windows to facilitate visual development and entrainment of circadian rhythms and sufficient space to accommodate physical and occupational therapy sessions.
When BPD is diagnosed, the BPD team develops individualized goals and expectations for each family and educates the family about the disease and the anticipated approach to care. This education ensures that families remain well-informed, with realistic expectations for and understanding of the care received by the infant.
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In addition to providing daily hospital care via bedside rounds, the BPD team meets weekly to discuss the details of care and the long-term therapeutic goals. These meetings allow all BPD team members (including those who will be rounding on weekends and holidays) to participate in the development of the care plan, fosters the culture of chronic care and minimizes variability in the delivery of clinical care. Finally, monthly attending physician meetings are held to review and discuss potentially better practices to assure that care is based on the most current evidence. Together, these meetings ensure excellent continuity of care over long, complex hospitalizations (Figure 1) .
Although the care of each infant in the CCBPD is highly individualized, several guiding principles apply to all patients. These principles include: (1) prevention of infection; (2) prevention of Cor pulmonale; (3) optimal nutrition for growth and repair; (4) intensive neurodevelopmental assistance lead by a team of OT, PT and speech therapists; and (5) minimalimpact respiratory support.
Prevention of infection. All central catheters are inserted and maintained using bundles, and formal assessments of their necessity and the potential to reduce line manipulation are documented daily. Central catheters are removed promptly on achievement of 120-140 ml kg À1 day À1 of enteral feeds, and the vast majority of patients are maintained without IV access. Strict hand hygiene is monitored and audited by the unit and patients are immunized according to the CDC schedules. During RSV season, palivizumab is administered immediately before discharge. Figure 1 Bronchopulmonary dysplasia (BPD) inpatient process. The inpatient flow of BPD patients and the management process. Between 28 and 56 days of life patients that are identified as highly likely to suffer BPD are entered into the comprehensive center for bronchopulmonary dysplasia (CCBPD). The CCBPD team then meets with the family, gathers intake information and begins weekly reviews of the plan of care. In collaboration with the family and based on assessments of the infant's disease state, nutritional status, and rate of current progress, the team sets realistic goals and expectations, including requirements for discharge. These plans of care are then reviewed weekly and monthly to assure that expectations are met; if the infant does not progress as expected, plans of care are recalibrated and new diagnostics may be required. As the patient progresses, discharge planning is emphasized and realistic home-going plans are determined with each family. Finally, before discharge, each family is introduced to the outpatient team and given redundant means of contacting the team, if problems occur.
Phase of BPD
Comprehensive BPD program improves care EG Shepherd et al Prevention of Cor pulmonale. All patients are fluid restricted with total daily volumes typically between 120 and 150 ml kg À1 day À1 ; occasional patients may require administration of less than 120 ml kg À1 day À1 . Oxygen saturations are maintained in target ranges, with a goal of >95% after 34 weeks. In patients with unstable respiratory status, echocardiograms are obtained and infants with signs of Cor pulmonale are treated with nitric oxide and/or sildenafil, in addition to supportive measures.
Optimal nutrition for growth and repair. Daily assessments by a dietician are a formal part of rounds, and Fenton growth charts are maintained and displayed at each bedside. Goal weight gain is 15-20 g kg À1 day À1 for infants <37 weeks PMA and 20 to 30 g per day thereafter. Patients typically require between 120 and 150 kCal kg À1 day À1 to achieve growth and repair in the setting of significant fluid restriction, which usually requires high calorie formula or highly fortified breast milk.
Intensive neurodevelopmental assistance. Patients receive developmental therapies three to five times per week while hospitalized. Treatments focus on creating an age-appropriate sensory and social environment, including promotion of normal sleep-wake cycles. Early in the course of BPD, therapy is limited to parental instruction related to their child's stress and self-regulatory behaviors, encouragement of kangaroo care, and facilitated tucking. As patients stabilize, the OTs and PTs assess respiratory tolerance to position changes, provide tactile, proprioceptive and vestibular input, facilitate state organization, and provide visual and auditory stimuli. A formalized neurodevelopmental assessment is carried out at about 40 weeks PMA (if still hospitalized), and subsequent therapies are directed at improving areas of delay.
Medical aspects of neurodevelopmental care include avoidance of noxious stimuli such as arterial and heel sticks (when possible), elimination of neuroactive substances such as opioids and sedatives and extremely rare usage of systemic corticosteroids.
Minimal-impact respiratory support. Patients are ventilated using synchronized intermittent mandatory ventilation. Patients with severe BPD typically have heterogeneous airway obstruction with air trapping, necessitating a slow respiratory rate to allow full exhalation. 12 The adequacy of respiratory support is evaluated using an objective scale, termed behavioral signs of respiratory instability, developed within the CCBPD, 13 and by regular evaluation of serum bicarbonate concentrations, with a goal of normal or only mildly elevated values. In the absence of an indwelling arterial line, blood gases do not reliably represent steady-state respiratory status and are thus only rarely obtained. 14, 15 Patients are routinely treated with inhaled steroids while ventilated, and many require regular administration of inhaled beta-agonists. Most patients with severe BPD are treated with furosemide, preferably scheduled twice daily every other day. 16 Once they are stable with an FiO 2 <0.4 on mechanical ventilation, patients are extubated to infant flow NCPAP, and transitioned to nasal cannula when NCPAP FiO 2 is <0.3. High-flow nasal cannula with the intent of providing positive pressure is not used. Patients typically are discharged to home on nasal cannula flows of 0.5 l per min or less, however, occasional patients have required up to 1.5 l per min to achieve adequate oxygenation.
A primary emphasis within the CCBPD is the safe and successful transition to home. Discharge planning is individualized based on the needs and abilities of both the family and the community. 17 Criteria for an infant to be discharged from the neonatal intensive care unit to home include: (1) a safe and stable oxygen need; (2) the ability to feed orally or a plan to advance feedings; (3) close coordination with a home-care company; (4) intensive involvement of a developmental service; and (5) careful coordination with a primary care physician. There are no gestational age or weight-based criteria for discharge.
Outpatient program
Every infant discharged on supplemental oxygen in central Ohio is followed by the CCBPD in our BPD outpatient clinic (Figure 2) , and those discharged on room air are followed in our neonatal developmental clinic. While the child remains on supplement oxygen, he/she is evaluated monthly and as needed. When the child no longer requires oxygen, he/she is followed for developmental, nutritional and social issues at longer intervals. At each clinic visit, the child and family are evaluated by a physician, a clinic nurse, a nutritionist, a social worker, a physical therapist and an occupational therapist. Patients are discharged by the BPD team once they are 2-3 years of age, and are transitioned to the neuropsychology department for continued developmental follow-up and the pulmonary service for continued respiratory care, if they still require respiratory support.
We provide intensive neurodevelopmental care for our outpatients, including formal developmental evaluations at 18 months corrected gestational age and at 24 months of age. Each developmental exam is conducted jointly by OT and PT using the Bayley Scales of Infant and Toddler Development (Bayley III) exam. 18 During the exam, the occupational therapist focuses on the mental development of the patient, whereas the physical therapist concentrates on psychomotor development.
Methods

Patients
Since the inception of the CCBPD in 2004, we have enrolled a total of 866 patients; of these, 273, all outborn, were enrolled as inpatients. Readmission rates are calculated using the denominator of patients within BPD outpatient clinic. Data for infants discharged on supplemental oxygen were not tracked reliably before 2003, and thus could not be included in our analyses.
Our developmental data are reported from all patients due for a developmental evaluation at either 18 months corrected gestational age or 24 months chronological age from March 2007 to September 2008 (n ¼ 126). We were able to perform evaluations on 107 patients (85%), whereas 10% had exams performed at other institutions and 5% were lost to follow-up. Like the National Institute of Child Health and Human development Neonatal Research Network (NICHD) NRN, we excluded patients who had a diagnosis of a grade III or IV intraventricular hemorrhage or periventricular leukomalacia. 6 Measures All infants in the CCBPD are assessed using the Bayley III exam. We compared our Bayley III 18 scores with the Bayley Scales of Infant Development (BSID) scores reported by the NICHD NRN in 2005. 6 Administration of each assessment is similar with regard to test items, however, they differ in that the Bayley III subdivides the components of the BSID II mental developmental index (MDI) into two categories, cognitive and language. The motor category of the Bayley III is analogous to the psychomotor developmental index of the BSID II. To compare our Bayley III data conservatively with the NICHD BSID II MDI results, we report the lowest score of the cognitive and language categories of the Bayley III. Thus, an infant that scored 65 on language but 75 on cognitive would be counted as having a combined score of 65. In addition, previous comparisons of the Bayley III and the BSID II mean scores showed that the Bayley III scores were B7 points higher than the BSID II MDI and psychomotor developmental index scores. 18, 19 Therefore, we ran the comparisons of our neurodevelopmental outcomes against those of the NICHD NRN two ways. First, we compared the rates of Bayley scores <70 at the CCBPD and as reported by the NICHD NRN. Second, to correct for the higher scores on the Bayley III, we compared the rate of patients within the CCBPD scoring less than 77, with the NICHD NRN patients scoring less than 70.
Standard medical and demographical information from the initial hospital stay, as well as data on outpatient complications and developmental assessments were collected on all patients. Readmission was defined as admission to the hospital within 1 month of first discharge and calculated as a percent of new patients seen.
Results
Readmission rates
Before initiation of the CCBPD the rate of readmission to the hospital for patients on supplemental oxygen was 29%. After initiation of the CCBPD in 2004, the rate of readmission declined to 3.1% and has remained under 10% every year thereafter (Figure 3 ).
Neurodevelopmental outcomes
A total of 61 patients with moderate BPD and 46 with severe BPD underwent neurodevelopmental evaluation at 18-24 months (Table 1 ). On average, these patients were born at 26 weeks 5 days Figure 2 Bronchopulmonary dysplasia (BPD) outpatient process. The outpatient flow of BPD patients and the management process. Outpatient care is focused on three parallel but related tracks. At each visit, medical, social and developmental concerns are addressed with the primary goal of assuring optimal neurodevelopment and avoiding complications. Proper nutrition and excellent growth are emphasized at every visit. The interdisciplinary team also attempts to anticipate potential problems before the next visit, and works prospectively with each family on action plans to deal with each likely concern. Finally, all medications and the need for supplemental oxygen are assessed at every visit, with the goal of safely reducing these therapies over time.
For patients with severe BPD, the CCBPD's rates of Bayley Cognitive and/or Language scores of <70 were significantly lower than the NICHD NRN rates (w 2 ¼ 20. 
Discussion
We developed the CCBPD in hopes of improving outcomes in patients with BPD by addressing medical, neurodevelopmental, social and systemic issues that impact these vulnerable patients. On the basis of the chronic care model, 20, 21 we instituted interdisciplinary care for infants with BPD. This model begins at diagnosis (often well before medical stabilization), continues through the transition to home and extends to the resolution of the illness. This comprehensive, team-oriented approach includes representatives from all disciplines including the family. It is designed with many redundancies to assure continuity of care, family satisfaction, adherence to the care plan and timely assessment and reevaluation.
The success of this program is evidenced, first, by the dramatic decrease in the 1-month post-discharge readmission rate for CCBPD patients. Second, neurodevelopmental outcomes of patients enrolled in the CCBPD are notably better for the Cognitive/ Language component of the Bayley III than those reported by the NICHD. No difference between the CCBPD and NICHD NRN was found on Bayley Motor scores, when we corrected Bayley III scores. We speculate that our success may be because of our attention to neurodevelopment throughout the hospitalization and our willingness to increase respiratory support to accommodate developmental therapies, activities of daily living and interaction with the environment.
Our neurodevelopment data are derived from the Bayley III tests, whereas the NICHD NRN used the Bayley II. The BSID is divided into two sections, the MDI and psychomotor developmental index, whereas the Bayley III is divided into three subsections, Cognitive, Language and Motor, potentially making comparisons problematic. To address these concerns, we carried out all comparisons as conservatively as possible by reporting the lower of the cognitive and language scores from the Bayley III results, and compared this with the MDI as reported by the NICHD. We also ran comparisons of Bayley III scores and Bayley II scores using both a 70-point and a 77-point cut score for the former. Finally, it is possible that the differences reported between our results and those of the NICHD could be because of differing populations or other confounding variables. We attempted to minimize these risks by using standardized and validated definitions to diagnose and characterize our patients with BPD, and used the same inclusion and exclusion criteria as the NICHD to determine eligibility for evaluation. Nevertheless, we are well aware of the difficulties associated with comparing single institutions with national averages, and hope that this work can represent the basis for prospective studies in the future. Figure 3 Readmission rate of infants with bronchopulmonary dysplasia (BPD) before and after the institution of the comprehensive center for bronchopulmonary dysplasia (CCBPD). Before 2004, infants discharged home on supplemental oxygen were followed by pediatricians with minimal assistance. The CCBPD was introduced in 2004, after which readmission rates significantly declined. This improvement in hospital readmission rate has been sustained for every subsequent year (*P<0.00002, w 2 , for each column vs 2003). 
Conclusion
The encouraging neurodevelopmental outcomes and readmission rates associated with a chronic care approach to BPD suggest these infants are best served by taking a comprehensive interdisciplinary approach to care that focused on neurodevelopment throughout the hospital stay, and pursued enhanced relationships among neonatologists, the patients and families, and referring physicians. Future research should focus on continued efforts to find ventilation and supportive care protocols that maximize infant development, and efforts to engage parents and providers as members of an integrated care team.
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